Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





CESIUM HYDROXIDE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 21351-79-1; **Chemical Formula:** CsOH
OSHA formerly had no limit for cesium hydroxide; however, based on the ACGIH recommendation, OSHA proposed the establishment of a 2-mg/m3 limit as an 8-hour TWA. NIOSH (Ex. 8-47, Table N1) concurred with OSHA’s proposed limit for this substance, and the Agency is establishing this limit for cesium hydroxide in the final rule. Cesium hydroxide is a colorless or yellowish fused crystalline mass; it is the strongest base known and is highly soluble in both water and alcohol.
Animal studies indicate that cesium hydroxide has an acute oral toxicity of about one-third that of potassium hydroxide, which causes lesions of the nasal septum and irritation of the eyes and respiratory tract (Karpov 1971/Ex. 1-1115). The oral LD(50) for cesium hydroxide in rats is 1016 mg/kg. Although a concentration of 5 percent cesium hydroxide did not produce skin irritation, contact with this concentration did result in severe eye irritation. Cesium hydroxide does not cause skin sensitization (Johnson, Lewis, and Perone 1972, as cited in ACGIH 1986/Ex. 1-3, p. 113). No rulemaking participants other than NIOSH commented on the proposed 2-mg/m3 TWA limit for cesium hydroxide.
In the final rule, the Agency is promulgating an 8-hour TWA PEL of 2 mg/m3 for cesium hydroxide and concludes that this limit will protect workers from the significant risk of severe eye irritation associated with exposure to this substance at levels above the new PEL. The Agency considers the severe eye irritation caused by exposure to cesium hydroxide a material impairment of health and functional capacity.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue